Chairman & Chief Executive Officer, Adapt Pharma
Mr. Seamus Mulligan, the founder of Adapt Pharma, serves as the Chairman and Chief Executive Officer. Previously Seamus founded and served as Chairman and Chief Executive Officer of Azur Pharma, which merged with Jazz Pharmaceuticals plc in 2012. Seamus continues to serve as a Director of Jazz Pharmaceuticals.
Prior to Azur Pharma, Seamus was closely involved, over a 20-year period, in Elan Corporation's growth and evolution from a drug delivery company into a research focused pharmaceutical organization.
Seamus holds a B.Sc (Pharm) and M.Sc from Trinity College, Dublin, Ireland.
Adapt Pharma is a specialty pharmaceutical company founded in November, 2013. Adapt Pharma are committed to positively impacting the lives of patients with specialist medical conditions.
They focus on adapting current medical knowledge to enhance existing and develop new medicines for those specific patient populations with unmet medical needs.
The company headquarters are in Dublin, Ireland. The business is focused on the US market and is led by the same team which founded Azur Pharma, plc. Azur Pharma merged with Jazz Pharmaceuticals, plc in 2012.